WCN24-2599 EFFICACY AND SAFETY OF BUDESONIDE IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Saved in:
| Main Authors: | João Lucas de Magalhães Leal Moreira, Elísio Santos Bulhões Júnior, Vânio Antunes do Livramento Junior, Beatriz Araújo, Giovanna Veiga Gomes, Vitor Expedito Alves Ribeiro, Roberto Augusto Mazetto Silva Vieira, Esther Patricia de Souza Borges, Erika Bião Lima Oliveira Sampaio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924001669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide
by: Christodoulos Keskinis, et al.
Published: (2025-04-01) -
Exploring the molecular mechanism of budesonide enteric capsules in the treatment of IgA nephropathy based on bioinformatics
by: Mengshu Lin, et al.
Published: (2025-08-01) -
A Targeted-Release Formulation of Budesonide for the Treatment of IgA Nephropathy Patients With Severe Renal Impairment
by: Yan Ouyang, et al.
Published: (2025-03-01) -
WCN25-3679 Open label, single arm, multicenter, prospective study on oral enteric coated budesonide therapy for primary IgA nephropathy
by: SANSHRITI CHAUHAN, et al.
Published: (2025-02-01) -
WCN24-2219 TRF-BUDESONIDE AND SPARSENTAN AS AN INITIAL THERAPY FOR PRIMARY IgA NEPHRITIS
by: Neeharik Mareedu, et al.
Published: (2024-04-01)